supp.fit

Vitamin D and Omega-3 Fatty Acids: study protocols

32 study groups took Vitamin D together with Omega-3 Fatty Acids. These are the doses the studies gave. They are not a recommendation.

Vitamin D: what the research found →

Dose per serving from research: Vitamin D

26 study groups in 25 studies say how much Vitamin D participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1,000 IU to 2,500 IU, 58% of 26 study groups.

Daily doseStudy groups
500 IU to 1,000 IU
3
1,000 IU to 2,500 IU
15
2,500 IU to 5,000 IU
1
5,000 IU to 10,000 IU
6
over 10,000 IU
1

Dose per serving from research: Omega-3 Fatty Acids

27 study groups in 26 studies say how much Omega-3 Fatty Acids participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mg to 1 g, 63% of 27 study groups.

Daily doseStudy groups
250 mg to 500 mg
2
500 mg to 1 g
17
1 g to 2.5 g
6
2.5 g to 5 g
1
over 5 g
1

Commonly used together

9 of 32 study groups took Vitamin D and Omega-3 Fatty Acids with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Fish Oil
3

32 study groups

Study
Safety and Tolerability of Targeted Medical Nutrition for Cachexia in Non-Small-Cell Lung Cancer: A Randomized, Double-Blind, Controlled Pilot Trial
2020 · juice-based TMN · Patients with non-small-cell lung cancer receiving first-line chemotherapy, with weight loss or low BMI
20 mcg2 g12 weeks26
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
2019 · n-3 fatty acids plus vitamin D group · Men aged 50 years or older and women aged 55 years or older, without selection for cardiovascular risk factors, in a primary-prevention trial
2,000 IU840 mg1936 days—
Effect of Vitamin D3 Supplements on Development of Advanced Cancer: A Secondary Analysis of the VITAL Randomized Clinical Trial
2020 · Vitamin D3 and marine omega-3 fatty acids active · Men aged 50 years or older and women aged 55 years or older without cancer or cardiovascular disease at study entry
2,000 IU1 g1937 days—
Effects of vitamin D, omega-3 fatty acids, and a simple home strength exercise program on fall prevention: the DO-HEALTH randomized clinical trial
2022 · Vitamin D plus marine omega-3 supplementation (exercise assignment varied) · Community-dwelling adults aged 70 years and older, generally healthy and active, without major health events in the prior 5 years
2,000 IU1 g3 years—
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease: A Novel Analysis of the VITAL Trial Using Win Ratio and Hierarchical Composite Outcomes
2023 · combination supplementation group · Men aged 50 years or older and women aged 55 years or older, free of known cardiovascular disease or cancer, from the general US population
2,000 IU1 g1935 days—
Vitamin D and Marine n-3 Fatty Acids for Autoimmune Disease Prevention: Outcomes Two Years After Completion of a Double-Blind, Placebo-Controlled Trial
2024 · Vitamin D and n-3 fatty acids · Men aged 50 years or older and women aged 55 years or older, recruited from the United States; prevention population without the trial's excluded serious illnesses
2,000 IU1 g1936 days—
Vitamin D supplementation vs. placebo and incident type 2 diabetes in an ancillary study of the randomized Vitamin D and Omega-3 Trial
2025 · Vitamin D plus marine omega-3 · Men aged 50 years or older and women aged 55 years or older, without type 2 diabetes at baseline; older US adults
2,000 IU840 mg1935 days—
Targeted medical nutrition for cachexia in chronic obstructive pulmonary disease: a randomized, controlled trial
2018 · TMN · Adults aged 50 years or older with moderate-to-severe COPD and pre-cachexia or cachexia
20 mcg4 g12 weeks22
The Effects of Omega-3 Fatty Acids and Vitamin D Supplementation on the Nutritional Status of Women with Breast Cancer in Palestine: An Open-Label Randomized Controlled Trial
2024 · group 3: both omega-3 and vitamin D supplementation (ω3+VitD) · Women aged 28–64 with newly diagnosed stage II or III breast cancer, before first chemotherapy treatment
7,143 IU600 mg9 weeks24
Inflammation (IL-1β) Modifies the Effect of Vitamin D and Omega-3 Long Chain Polyunsaturated Fatty Acids on Core Symptoms of Autism Spectrum Disorder-An Exploratory Pilot Study(‡)
2020 · vitamin D and omega-3 LCPUFA (VIDOM) · Children aged 2.5–8 years with autism spectrum disorder
2,000 IU722 mg1 year15
Effect of vitamin D and omega-3 on nocturnal enuresis of 7-15-year-old children
2018 · Group C · Children aged 7–15 with nocturnal enuresis
1,000 IU1 g60 days—
Low-Dose Omega-3 Fatty Acid and Vitamin D for Anthropometric, Biochemical Blood Indices and Respiratory Function. Does it work?
2020 · experimental group · Office workers aged 40–60 years; sex and health condition not stated
5 mcg330 mg16 weeks—
Effect of Vitamin D Supplementation on Overactive Bladder and Urinary Incontinence Symptoms in Older Men: Ancillary Findings From a Randomized Trial
2023 · vitamin D plus omega-3 fatty acids · Men aged 50 and older without clinically apparent cardiovascular disease or cancer; this analysis excluded men with multiple sclerosis or Parkinson’s disease at baseline
2,000 IU—1935 days—
The effects of Omega-3 fatty acids and vitamin D supplementation on the quality of life and blood inflammation markers in newly diagnosed breast cancer women: An open-labelled randomised controlled trial
2025 · ω3+VitD group · Women newly diagnosed with breast cancer receiving chemotherapy; age range not reported
7,143 IU600 mg9 weeks—
Effects of vitamin D3, omega-3 fatty acids and a simple home exercise program on change in physical activity among generally healthy and active older adults: The 3-year DO-HEALTH trial
2025 · Vitamin D3 and omega-3s, without SHEP · Generally healthy, community-dwelling adults aged 70 years or older; men and women
2,000 IU1 g3 years—
Effects of vitamin D3, omega-3 fatty acids and a simple home exercise program on change in physical activity among generally healthy and active older adults: The 3-year DO-HEALTH trial
2025 · Vitamin D3 and omega-3s with SHEP · Generally healthy, community-dwelling adults aged 70 years or older; men and women
2,000 IU1 g3 years—
Effects of a 6-Month Multifaceted Diet and Exercise Intervention on Cognition in Older Adults at Risk of Cognitive Decline: The PONDER Double-Blind, Placebo-Controlled Randomized Trial
2022 · Multimodal exercise program with daily supplement · Community-dwelling older adults with subjective memory impairment; mean age 70.2 years, 70% female
1,000 IU1.5 g26 weeks73
Effect of Omega-3 Polyunsaturated Fatty Acid Supplementation on Clinical Outcome of Atopic Dermatitis in Children
2024 · intervention group · Children aged 1–8 years with moderate-to-severe atopic dermatitis
5 mcg600 mg120 days26
The effects of omega-3 fatty acid on vitamin D activation in hemodialysis patients: a pilot study
2015 · Cholecalciferol with omega-3 FA group · Hemodialysis patients with baseline 25(OH)D levels below 30 ng/mL; mean age 62.1 years; 33.3% men
7,143 IU2.4 g12 weeks8
Combined Effect of Omega-3 Fatty Acid and Vitamin D 3 on Oxidized LDL-C and Non-HDL-C Levels in People With Vitamin D Deficiency: A Randomized Controlled Trial
2023 · D+ group · Jordanian participants with vitamin D deficiency and no other medical conditions; age and sex not specified
7,143 IU300 mg8 weeks47
The effects of fish oil plus vitamin D(3) intervention on non-alcoholic fatty liver disease: a randomized controlled trial
2022 · FO + D group · Adults aged 56.0 ± 15.9 years with non-alcoholic fatty liver disease
1,680 IU2.34 g90 days37
Multiple Micronutrients, Lutein, and Docosahexaenoic Acid Supplementation during Lactation: A Randomized Controlled Trial
2020 · MMS group · Healthy breastfeeding women, aged 18–45 years, beginning supplementation 4–6 weeks after delivery
600 IU—12 weeks35
Impact of Omega-3 and Vitamin D Supplementation on Bone Turnover Markers in Children with Leukemia: Follow-Up During and After Supplementation
2025 · ω-3VDCa group · Children aged 5–17 years with acute lymphoblastic leukemia in the maintenance phase
4,000 IU100 mg/kg6 weeks19
The Effect of Omega-3 Fatty Acid Supplementation on Serum Adipocytokines, Lipid Profile and Biochemical Markers of Inflammation in Recreational Runners
2021 · ω-3 PUFA group · Healthy physically active male recreational marathon runners, with no stated disease; age range not reported
30 mcg2.45 g3 weeks12
Randomized Study of the Effect of Vitamin D and Omega-3 Fatty Acids Cosupplementation as Adjuvant Chemotherapy on Inflammation and Nutritional Status in Colorectal Cancer Patients
2020 · cosupplementation group · Colorectal cancer patients
7,143 IU—8 weeks—
Prenatal dietary supplements influence the infant airway microbiota in a randomized factorial clinical trial
2020 · n-3 LCPUFA plus vitamin D · Pregnant women enrolled at pregnancy week 24; age range and health condition not specified
2,400 IU2.4 g17 weeks—
Effects of Vitamin D and Omega-3 Fatty Acids Co-Supplementation on Inflammatory Factors and Tumor Marker CEA in Colorectal Cancer Patients Undergoing Chemotherapy: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
2020 · co-supplementation · Patients with stage II or III colorectal cancer undergoing chemotherapy
7,143 IU—8 weeks—
The effect of combined supplementation with vitamin D and omega-3 fatty acids on blood glucose and blood lipid levels in patients with gestational diabetes
2021 · test group · Women aged 18–40 with gestational diabetes
80,000 IU16 g6 weeks—
Effects of Vitamin D(3) and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial
2022 · Vitamin D3 and marine n-3 fatty acids active group · Men aged 50 years or older and women aged 55 years or older, without a history of cancer (except non-melanoma skin cancer), myocardial infarction, stroke, transient ischemic attack, or coronary revascularization
2,000 IU1 g1935 days—
Vitamin D(3) and marine ω-3 fatty acids supplementation and leukocyte telomere length: 4-year findings from the VITamin D and OmegA-3 TriaL (VITAL) randomized controlled trial
2025 · Vitamin D3 plus marine n-3 fatty acids · Females aged 55 years or older and males aged 50 years or older; no specific condition stated
2,000 IU1 g5 years—
Multimicronutrient and omega-3 fatty acid supplementation reduces low-grade inflammation in older participants: An exploratory study
2025 · multimicronutrient and n-3 PUFA supplementation · Healthy, physically active older adults; mean age 75.6 ± 3.9 years; sex not specified
50 mcg1 g12 weeks—
Effects of Vitamin D, Omega-3 Fatty Acids and a Home Exercise Program on Prevention of Pre-Frailty in Older Adults: The DO-HEALTH Randomized Clinical Trial
2023 · Vitamin D3 plus marine omega-3s · Generally healthy, robust, community-dwelling adults aged 70 years or older
2,000 IU1 g3 years—
Vitamin D and Omega-3 Fatty Acids: study protocols | supp.fit